NXT Biomedical
- Company typePrivate
- Founded2018
- HeadquartersIrvine, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
NXT Biomedical firmographics
Firmographics- Name
- NXT Biomedical
- Legal name
- NXT Biomedical, LLC
- Website
- https://nxtbiomedical.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
NXT Biomedical industry classification
Industry- Product category
- Medical Device Incubator
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Corporate Venture Studios & Incubators (Build/launch ventures) (FSANAHAC)
- akta.pro secondary industry
- Corporate Deep Tech / R&D Commercialization CVC (FSANAHAL)
Keywords
Where NXT Biomedical is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NXT Biomedical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations
NXT Biomedical product offering
Product offeringCore offering
NXT Biomedical is a medical device incubator that invests in intellectual property and develops breakthrough biomedical technologies to spin out multiple startups over a five-year horizon. The incubator partners with Deerfield Management, committing $25 million over five years to fund cutting-edge medical technologies addressing unmet clinical needs, with the goal of launching 5 to 8 startups that bring clinically relevant medical devices to market. Each spun-out entity is designed to deliver technologies that improve patient outcomes and reduce healthcare system costs.
Product overview
NXT Biomedical is a biomedical technology incubator rather than a product company. It is structured as a platform for developing medical device startups, with a stated vision to invest $25 million over five years to create five to eight startups spun out of the incubator. Each startup is intended to bring clinically relevant medical technology to market. The incubator partners with Deerfield Management and is led by medtech pioneer Stanton Rowe. No specific named products, modules, or commercial offerings have been launched yet, as the company is in the early-stage feasibility and startup development phase.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Device Startup Incubation Program
Companies that use NXT Biomedical
Customer profileSegments1 record
Ideal customer profiles2 records
NXT Biomedical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
NXT Biomedical partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights5 records
NXT Biomedical competitors and assessment
Company assessmentDirect peers
- ExploraMed: Medical device incubator founded by Josh Makower that creates and funds early-stage device companies addressing large unmet clinical needs; directly analogous business model to NXT, operating as a venture studio rather than a fund.
- InCube Labs: Life sciences-focused venture studio that incubates and develops medical device and therapeutic ventures from internal IP; matches NXT on the model of internal IP generation followed by spin-out of operating companies.
- Fogarty Institute for Innovation: Nonprofit medtech incubator that mentors physicians and engineers and spins out device startups; comparable in mission (developing breakthrough medical technologies and launching startups) and in operating as an incubator rather than a commercial product company.
- The Foundry: Medical device-focused venture studio that conceives, incubates, and spins out new medtech companies using a similar model to NXT Biomedical: small core team, multiple parallel programs targeting unmet clinical needs, and reliance on a network of serial entrepreneurs.
Broad incumbents
- Edwards Lifesciences: Large medtech incumbent where Stanton Rowe previously served as CSO; provides a natural acquisition channel and benchmark for the strategic exit lane that NXT's spin-outs would target, plus the corporate venture posture against which NXT competes for talent.
- Stryker: Diversified medical device incumbent with an active corporate development and venture function; comparable because NXT spin-outs could be evaluated for acquisition and Stryker's portfolio illustrates the type of strategic outcomes NXT's model targets.
- Johnson & Johnson Innovation / JLABS: Corporate venture and incubator arm of J&J, where Rowe previously led business development at JJIS; directly relevant as an incumbent-sponsored model that supports early-stage medtech startup formation and competes for both founders and technologies.
- Deerfield Management: Healthcare-focused investment firm and NXT's named capital partner; not a direct competitor but the most thematically adjacent funder — meaningful for benchmarking capital availability, program economics, and downstream syndication in the medtech venture studio category.
- Medtronic: One of the world's largest medical device companies; relevant as both a potential acquirer of NXT spin-outs and a competitor for sourcing IP and engineering talent, shaping the strategic landscape NXT operates within.
Emerging players
- InSeal Medical: Early-stage medical device company on whose board Stanton Rowe serves as a Director; useful as a small, comparable operating company that illustrates the kind of venture a platform like NXT might produce or collaborate with.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
NXT Biomedical social profiles
Digital presenceNXT Biomedical financial estimates
Financial estimateRevenue estimate
Valuation estimate
NXT Biomedical leadership team
Management profileNumber of profiles
Profiles3 records
NXT Biomedical funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NXT Biomedical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NXT Biomedical
What does NXT Biomedical do?
NXT Biomedical is a medical device incubator that invests in intellectual property and develops breakthrough biomedical technologies to spin out multiple startups over a five-year horizon. The incubator partners with Deerfield Management, committing $25 million over five years to fund cutting-edge medical technologies addressing unmet clinical needs, with the goal of launching 5 to 8 startups that bring clinically relevant medical devices to market. Each spun-out entity is designed to deliver technologies that improve patient outcomes and reduce healthcare system costs.
Is NXT Biomedical a public or private company?
NXT Biomedical is a private company. It is classified as venture growth investor backed and is currently operating.
When was NXT Biomedical founded?
NXT Biomedical was founded in 2018. It employs 1 to 10 people.
Where is NXT Biomedical based?
NXT Biomedical is headquartered in Irvine, United States, in the North America region.
Who are NXT Biomedical's main competitors?
Direct peers on record are ExploraMed, InCube Labs, Fogarty Institute for Innovation and The Foundry. Broad incumbents are Edwards Lifesciences, Stryker, Johnson & Johnson Innovation / JLABS, Deerfield Management and Medtronic. InSeal Medical is listed as an emerging player.
Does NXT Biomedical have an API?
No public API is recorded for NXT Biomedical.
What industry is NXT Biomedical in?
NXT Biomedical's product category is Medical Device Incubator. Its primary akta.pro industry code is FSANAHAC, Corporate Venture Studios & Incubators (Build/launch ventures), with a secondary code of FSANAHAL, Corporate Deep Tech / R&D Commercialization CVC. Its NAICS code is 5417 and its SIC code is 3841.